Trading on June 18, 2026 was packed with earnings reports and new IPO listings, set against a positive market backdrop as the US and Iran signed an interim peace agreement.

Accenture: earnings beat, revenue miss — stock craters 19%

Consulting and technology giant Accenture (NYSE: ACN) reported Q3 FY2026 results. EPS came in at $3.80, beating the consensus estimate of $3.71. Revenue totaled $18.72 billion, up 6% in USD terms but slightly below street expectations of ~$18.78 billion.

Investors focused on the negatives: new bookings fell 2-3% YoY to $19.3 billion, and the company narrowed its full-year local-currency revenue growth guidance to 3%-4% from 3%-5%, citing weakness in US federal government spending.

The result: ACN shares plunged 17%-19% during the session to around $128-$130, making it one of the S&P 500's worst performers of the day.

Kroger: slight EPS miss sends stock down 8%

Grocery chain Kroger (NYSE: KR) reported Q1 2026 results. Total sales came in at $46.1 billion, up from $45.1 billion a year earlier. Adjusted EPS was $1.58, narrowly missing the $1.59 consensus.

Despite the small miss, the stock fell about 7%-8% intraday to ~$57 — Kroger's steepest single-day drop in years. Identical-store sales grew 1.0%, while e-commerce sales jumped 19%. The company reaffirmed its full-year adjusted EPS guidance of $5.10-$5.30.

Three IPOs hit the market

Three companies began trading on US exchanges today:

Kardigan (NASDAQ: KARD) — A clinical-stage cardiovascular biotech. It priced 25 million shares at $16 (the top of the range), raising $400 million in an upsized IPO — the largest clinical biotech IPO this year. Shares opened at $16.25 and gained roughly 2% in early trading. Market cap stands at approximately $1.43 billion.

Deep Fission (NASDAQ: FISN) — An advanced nuclear energy company developing underground small modular reactors (SMRs). Priced at $16 per share, raising $40 million — well below the original $150-$156 million target from its initial filing.

First Carolina Financial Services (NYSE: FCBM) — A community bank holding company serving the US Southeast. Priced at $12.50 per share, below its $14-$16 range, raising $68.8 million. The stock traded around $12.84 on its first day.

Broader market rallies on Iran deal

The interim US-Iran peace agreement — signed in recent days, initiating 60 days of negotiations — sparked broad market optimism. The Nasdaq Composite gained 1%-1.7%, the S&P 500 rose roughly 1%, and the Dow Jones advanced about 0.35%. Oil prices fell on the reopening of the Strait of Hormuz.

Bottom line

Accenture's disappointing report — and the violent stock reaction — dominated the day. The new IPOs provided a reminder that biotech demand remains strong, while nuclear and regional banking IPOs faced pricing headwinds. The IPO pipeline continues to recover, but the path is uneven.